ArticleCureus2025
Idiopathic Juvenile Osteoporosis Diagnosed in Adulthood: The First Documented Case in Georgia.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Idiopathic juvenile osteoporosis (IJO) is a rare metabolic bone disorder characterized by bone fragility in otherwise healthy children and adolescents, with typical onset before puberty. To our knowledge, this represents the first documented case of IJO in Georgia, with a delayed diagnosis in adulthood despite a clinical history suggestive of earlier onset. A 24-year-old male with a history of childhood nephrolithiasis and intermittent vitamin D deficiency presented with progressive bone pain, joint crepitus, and worsening mobility. Imaging revealed severe osteopenia and osteoporosis, prompting an extensive metabolic and endocrine evaluation. Laboratory findings were largely unremarkable aside from episodic hypercalciuria, normal parathyroid hormone levels, and fluctuating vitamin D levels. Major secondary causes, including malignancy, hyperparathyroidism, thyroid dysfunction, chronic inflammatory disease, and malabsorption syndromes, were ruled out. A diagnosis of IJO was made by exclusion. The patient was started on calcium and vitamin D supplementation with close monitoring. This case highlights the diagnostic challenges of IJO when presentation extends into adulthood and underscores the importance of considering this condition in young adults with unexplained bone fragility, particularly in regions where it remains undocumented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.